A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) ...
A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better ...
Recent Updates in Basic Research, Drug Discovery and Treatment - Volume II", we are pleased to announce the launch ...
Three Philadelphia scientists won a $3 million Breakthrough Prize for developing the first FDA-approved gene therapy for a ...
A new update from the (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma ...
The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered ...
A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma (HCC), the leading cause of ...
InvestorsHub on MSN
Aligos Therapeutics jumps on China licensing agreement
Aligos Therapeutics Inc. (NASDAQ:ALGS) shares surged 20% on Thursday after the company announced an exclusive licensing deal ...
Aligos to receive an upfront payment of $25M USDUp to $420M USD in clinical, regulatory, and sales milestones along with tiered, high ...
Precision BioSciences, Inc. (DTIL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 9:30 AM EDTCompany ParticipantsJohn Kelly - CFO ...
Primary liver cancer continues to pose a major global health challenge, ranking as the third leading cause of cancer-related deaths worldwide.
Despite new rules, vulnerable groups are often unaware of informed consent and provisions for compensation in case of adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results